Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antioxidant Effects on the Outcome of Ovarian Cancer
NCT00228319Phase 2Completed
- Start
- Oct 2002
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ascorbic acid in ovarian cancer. Started Oct 2002; status: completed.
02
Drugs
ascorbic acid
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00228319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00228319.